Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.

BMJ (Clinical research ed.)·2026
Same author

Exposure to multiple metallic elements and risk of thyroid tumors: insights from elemental profiling, diet, and molecular characteristics plasma levels of metallic elements.

Frontiers in oncology·2026
Same author

Machine Learning Multiorgan Analysis of Coronary CT Angiography Body Composition, Myocardial Infarction, and Mortality in the SCOT-HEART Trial.

Radiology·2026
Same author

Supratopological Ion-Coordinated Binder Networks for Durable and Kinetically Efficient Silicon Anodes.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review).

International journal of molecular medicine·2026
Same author

Rare <i>BRCA1</i> c.3418_3419insTGACTACT:p.S1140Mfs*18 germline mutation in a family with breast and ovarian cancer.

Oncology letters·2026

相关实验视频

Updated: Jun 25, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

多重原发性肺癌:最新情况和前景

Ziqi Wang1,2, Quncheng Zhang1,2, Chaoyang Wang1,2

  • 1Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.

International journal of cancer
|May 24, 2024
PubMed
概括

管理多重原发性肺癌 (MPLC) 是复杂的,由于发病率的增加和诊断挑战. 本综述探讨了MPLC的分子特征,诊断和治疗方法,为未来的研究提供了见解.

关键词:
病因 病因学 病因学管理的管理管理的管理.多种原发性肺癌是多种原发性肺癌.这是下一代测序.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.9K

相关实验视频

Last Updated: Jun 25, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.9K

科学领域:

  • 在瘤学瘤学.
  • 肺部病理学 肺部病理学
  • 医疗成像医学成像

背景情况:

  • 多重原发性肺癌 (MPLC) 的发病率正在增加,特别是低剂量计算机断层扫描查的进展发现了更多的肺结节.
  • 对MPLC的发病,诊断标准和治疗选择都带来了重大的临床挑战.
  • 了解MPLC对于改善患者治疗结果至关重要.

研究的目的:

  • 审查目前关于MPLC分子特征的知识.
  • 探索MPLC的新型诊断方法和新兴治疗方式.
  • 提供洞察力,并激发MPLC管理的未来研究.

主要方法:

  • 文献综述,重点关注MPLC研究的最新进展.
  • 对剖析MPLC分子特征的研究进行分析.
  • 检查MPLC的新诊断和治疗策略.

主要成果:

  • 新出现的证据凸显了MPLC中分子分析的重要性.
  • 新的诊断工具正在开发中,以更好地区分MPLC与肺内转移.
  • 正在研究创新的治疗策略,包括向疗法和免疫疗法.

结论:

  • 有效管理MPLC需要对其分子景观有全面的了解.
  • 对诊断和治疗的持续研究对于推进MPLC护理至关重要.
  • 本综述综合了当前的证据,以指导MPLC的未来临床实践和研究工作.